Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-06-28
2005-06-28
Fredman, Jeffrey (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100
Reexamination Certificate
active
06911308
ABSTRACT:
The present invention provides methods for determining the status of anH. pyloriinfection by detecting a high-integrityH. pylorinucleic acid in a patient sample.
REFERENCES:
patent: 5401631 (1995-03-01), Lane et al.
patent: 5670325 (1997-09-01), Lapidus et al.
patent: 5705332 (1998-01-01), Roll
patent: 5741650 (1998-04-01), Lapidus et al.
patent: 5795717 (1998-08-01), Nakayama et al.
patent: 5830665 (1998-11-01), Shuber et al.
patent: 5888778 (1999-03-01), Shuber
patent: 5928870 (1999-07-01), Lapidus et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5958686 (1999-09-01), Houng
patent: 6020137 (2000-02-01), Lapidus et al.
patent: 6100029 (2000-08-01), Lapidus et al.
patent: 6143529 (2000-11-01), Lapidus et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6203993 (2001-03-01), Shuber et al.
patent: 6214187 (2001-04-01), Hammond et al.
patent: 6214558 (2001-04-01), Shuber et al.
patent: 6238927 (2001-05-01), Abrams et al.
patent: 6251660 (2001-06-01), Muir et al.
patent: 6268136 (2001-07-01), Shuber et al.
patent: 6280947 (2001-08-01), Shuber et al.
patent: 6300077 (2001-10-01), Shuber et al.
patent: 6303304 (2001-10-01), Shuber et al.
patent: 6351857 (2002-03-01), Slaon, III et al.
patent: 2001/0018180 (2001-08-01), Shuber et al.
patent: 2002/0004201 (2002-01-01), Lapidus et al.
patent: 2002/0025525 (2002-02-01), Shuber
patent: 2002/0045183 (2002-04-01), Shuber et al.
patent: 2002/0048752 (2002-04-01), Lapidus et al.
patent: 2002/0064787 (2002-05-01), Shuber et al.
patent: 2002/0119469 (2002-08-01), Shuber et al.
patent: 2002/0119472 (2002-08-01), Lapidus et al.
patent: 2002/0123060 (2002-09-01), Boles et al.
patent: 2002/0132251 (2002-09-01), Shuber
patent: 2002/0164631 (2002-11-01), Shuber et al.
patent: 2002/0172955 (2002-11-01), Adams et al.
patent: 2003/0044780 (2003-03-01), Lapidus et al.
patent: 711754 (1997-07-01), None
patent: 704696 (1997-08-01), None
patent: 730491 (1998-11-01), None
patent: 720489 (1999-09-01), None
patent: 2211702 (1999-05-01), None
patent: WO 91/09049 (1991-06-01), None
patent: WO 00/29618 (2000-05-01), None
patent: WO 00/50640 (2000-08-01), None
patent: WO 00/70096 (2000-11-01), None
patent: WO 01/18252 (2001-03-01), None
patent: WO 01/42502 (2001-06-01), None
patent: WO 01/42503 (2001-06-01), None
patent: WO 01/42781 (2001-06-01), None
patent: WO 01/53817 (2001-07-01), None
patent: WO 01/64950 (2001-09-01), None
patent: WO 02/059379 (2002-08-01), None
Gramley W A et al. Detection ofHelicobacter pyloriDNA in Fecal Samples. J. Clin. Microbiol., vol. 37 (7), pp. 2236-2240, 1999.
Li et al. A newly developed PCR assay ofH. pyloriin gastric biopsy, saliva, and feces. Digestive Diseases and Sciences, vol. 41(11), pp. 2142-2149, 1996.
Chong et al. Evaluation of 16S rRNA gene PCR with primers Hp1 and Hp2 for detection ofHelicobacter pylori. J Clin Microbiol., vol. 34(11): 2728-2730, 1996.
Li C et al. High prevalence ofHelicobacter pyloriin saliva demonstrated by a novel PCR assay. J Clin Pathol., vol. 48: 662-666, 1995.
Anderson, J., “H pyloriinfection: Review of the guideline for diagnosis and treatment,”Geriatrics 55: 44-49 (Jun. 2000).
Caselli et al., “Diagnosis ofHelicobacter pyloriinfection by HpSA test,”Lancet, 354(9185): 1209-1210.
Correa et al., “Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pyloriTherapy,”J. National Cancer Institute, 92(23): 1881-1888 (Dec. 2000).
Costa et al., “Post-treatment diagnostic accuracy of a new enzyme immunoassay to detectHelicobacter pyloriin stools.”Aliment. Pharmacol. Ther., 15: 395-401 (2001).
Doig et al., “Helicobacter pyloriPhysiology Predicted from Genomic Comparison of Two Strains,”Microbiol. and Molecular Biol. Reviews, 63(3): 675-707 (Sep. 1999).
Duggan, A.E., “Testing forHelicobacter pyloriinfection: validation and diagnostic yield of a near patient test in primary care,”British Medical Journal, 319: 1236-1239 (Nov. 1999).
Dunn et al., “Helicobacter pylori,”Clin. Microbiol. Reviews, 10(4): 720-741 Oct. 1997).
Forné et al., “Accuracy of an Enzyme Immunoassay for the Detection ofHelicobacter pyloriin Stool Specimens in the Diagnosis of Infection and Posttreatment Check-Up,”Am. J. Gastroenter., 95(9): 2200-2205 (Sep. 2000).
Fox et al., “Helicobacter pylori—Not a Good Bug After All,”N. Engl. J. Med., 345(11): 829-832 (Sep. 2001).
Gramley et al., “Detection ofHelicobacter pyloriDNA in Fecal Samples from Infected Individuals,”J. Clin. Microbiol., 37(7): 2236-2240 (Jul. 1999).
“H. pyloriDrug Resistance a Growing Problem in Germany,”Reuters Medical News, downloaded from www.medscape.com/viewarticle/429645_print on Mar. 13, 2002.
“H. pyloriEradication May Improve Platelet Count in Thrombocytopenia,”Reuters Medical News, downloaded from http://gastroenterology.medscape.com/reu.../prof/2001/02/02.09/20010208clin005.htp on Feb. 12, 2001.
“Helicobacter pyloriand Gastric Lymphoma: A Dangerous Connection,”Medscape Hematology—Oncology, 4(2): (2001), downloaded from http://gastroenterology.medscape.com/Medscape/oncology/journal/2001/v04.n02/ca-mo042... on Apr. 29, 2001.
Herbrink et al., “Serological Methods for Diagnosis ofHelicobacter pyloriInfection and Monitoring of Eradication Therapy,”Eur. J. Clin. Microbiol. Infect. Dis., 19: 164-173 (2000).
Ishihara et al., “Diagnostic accuracy of a new non-invasive enzyme immunoassay for detectingHelicobacter pyloriin stools after eradication therapy,”Aliment. Pharmacol. Ther., 14: 611-614 (2000).
Kerr et al., “An association between sudden infant death syndrome (SIDS) andHelicobacter pyloriinfection,”Arch. Dis. Child., 83: 429-434 (2000).
Marais et al., “Metabolism and Genetics ofHelicobacter pylori: the Genome Era,”Microbiol. and Molec. Biol. Reviews. 63(3): 642-674 (Sep. 1999).
Moayyedi et al., “The effectiveness of omeprazole, clarithromycin and tinidazole in eradicatingHelicobacter pyloriin a community screen and treat programme,”Aliment. Pharmacol. Ther., 14: 719-728 (2000).
Monteiro et al., “Detection ofHelicobacter pyloriDNA in human feces by PCR: DNA stability and removal of inhibitors,”J. Microbiol. Meth., 45: 89-94 (2001).
Monteiro et al., “Magnetic Immuno-PCR Assay with Inhibitor Removal for Direct Detection ofHelicobacter pyloriin Human Feces,”J. Clin. Microbiol., 39(10): 3778-3780 (Oct. 2001).
Ni et al., “Accurate diagnosis ofHelicobacter pyloriinfection by stool antigen test and 6 other currently available tests in children,”J. Pediatrics, 136(6): 823-827 (Jun. 2000).
Nilsson et al., “HelicobacterSpecies Identified in Liver From Patients With Cholangiocarcinoma and Hepatocellular Carcinoma,”Gastroenterology, 120(1): 323-326 (Jan. 2001).
Peña et al., “Molecular Resistance Testing ofHelicobacter pyloriin Gastric Biopsies,”Arch. Pathol. Lab. Med., 125: 493-497 (Apr. 2001).
Peterson et al., “Helicobacter pylori, ” in Slesinger et al.,Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, Philadelphia: W.B. Saunders, 1998: 604-615.
Shepherd et al., “Comparison of an enzyme immunoassay for the detection ofHelicobacter pyloriantigens in the faeces with the urea breath test,”Arch. Dis. Child., 83: 268-270 (2000).
Shuber et al., “Accurate Non-invasive Detection ofH. pyloriDNA before and After Treatment,” oral presentation, (May 2001).
Uemura et al., “Helicobacter pyloriinfection and the Development of Gastric Cancer,”New England J. of Med., 345(11): 784-789 (Sep. 2001).
Vaira, D., “Diagnosis ofHelicobacter pyloriinfection with a new non-invasive antigen-based assay,”Lancet, 354: 30-33 (Jul. 1999).
Yamamoto et al., “A New Rapid Test for Detecting Anti-Helicobacter pyloriAntibody Excreted into Urine,”Helicobacter, 5(3): 160-164 (2000).
Zipser et al., “Is R
Biswas, Esq. Naomi S.
Chunduru Prabha
Elrifi, Esq. Ivor R.
Exact Sciences Corporation
Fredman Jeffrey
LandOfFree
Methods for detecting, grading or monitoring an H. pylori... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting, grading or monitoring an H. pylori..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting, grading or monitoring an H. pylori... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3509141